3d Bioprinting Market
3d Bioprinting Market by Technology (Inkjet-based, Magnetic Levitation, Syringe-based, Laser-based), by Application (Medical, Dental, Biosensors, Consumer/Personal Product Testing), by Region (North America, Latin America, Europe, Asia Pacific) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)
Market Snapshot
| 3d Bioprinting Market Forecast Year: | 2022 - 2028 |
| 3d Bioprinting Market Historical Year: | 2016 - 2021 |
| 3d Bioprinting Market 2021: | USD 1.5 Billion |
| 3d Bioprinting Projected Market 2028: | USD 1.8 Billion |
| 3d Bioprinting Market CAGR: | 13.6% |
| Fastest Growing Region: | Asia Pacific |
| Largest Region: | North America |
3d Bioprinting Market: By Technology, Application, and Region
Market Synopsis:
Global 3d Bioprinting market is valued at USD 1.5 Billion in 2021 and is projected to attain a value of USD 1.8 Billion by 2028 at a CAGR of 13.6% during the forecast period, 2022–2028. The stem cell and regenerative medicine industries are expanding around the world, thanks to increased stem cell research efforts and financial assistance from a number of public-private partnerships. The availability of a large number of stem cell product pipelines, as well as applications of regenerative medicine in the treatment of diseases, are all key elements contributing to the growing adoption of stem cell and regenerative medicine around the world. In regenerative medicine, 3d Bioprinting is employed in a variety of ways. It's employed in the growth of bodily parts including cartilage, the heart, and the liver, among other organs, as well as the treatment of various diseases. Similarly, stem cells are employed extensively for bioprinting various bones and tissues. These cells are easily adaptable to growth agents and can form the necessary 3D structures.
As the number of people infected with COVID-19 rises, there is a shortage of supplies for medical professionals and the general public. One of the most serious difficulties is the scarcity of COVID-19 test kits. As a result, a number of 3d Bioprinting businesses are mass-producing 3D printers and related software. For example, the Formlabs company in Massachusetts is already producing 100,000 nasal swabs every day for COVID-19 testing. The need for 3d Bioprinting is increasing as the number of instances of COVID-19 rises, and the market for 3d Bioprinting is predicted to develop at an exponential rate.
Technological Advancements in the 3D Bioprinting Industry
The use of 3d Bioprinting technology in the healthcare business has grown in recent years. 3d Bioprinting has emerged as a promising method for fabricating artificial tissues and organs, with the potential to transform medical diagnosis and treatment. 3d Bioprinting companies around the world are constantly innovating in regenerative medicine, tissue engineering, drug therapies, and stem cell therapy, which is attracting the attention of healthcare professionals and pharmaceutical companies who see a future with better patient care, personalized medical treatment, and an alternative to organ transplantation.
A dearth of Skilled Professionals
3D bioprinting is a new field in the healthcare industry that is seeing rapid technological improvements, which is driving up need for trained personnel who can run these systems successfully. Continuous process monitoring is required for optimal usage of 3D bioprinting technology. Due to uncontrollable process variables (such as batch and machine differences) and material differences, the consistency of the process differs across platforms. These technologies and processes necessitate the expertise of a trained individual who can comprehend and effectively operate a 3D bioprinter.
Market Segmentation:
Global 3d Bioprinting market is segmented on the basis of Technology into Magnetic, Levitation, Inkjet-based, Syringe-based, Laser-based and Others. Based on application, the 3d Bioprinting market is segmented into Medical, Dental, Biosensors Consumer/Personal Product Testing, Bioinks and Food and Animal Product. Based on region, the 3d Bioprinting market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Below tree is interactive. You can click the nodes to get more information.
North America to Continue Dominating the 3d Bioprinting Market
In 2020, North America dominated the 3d Bioprinting market over the forecast period. The market is expected to rise due to the increasing adoption of IT in the healthcare industry. The government is increasing its research and development budget in an attempt to create a vaccine for this disease. As a result of this, there is a growing need for 3D bioprinting, which has been validated for drug testing and organ transplantation.
Key Players:
Some of the players in the 3d Bioprinting market is Envisiontec, Inc., Organovo Holdings, Inc., Inventia Life Science PTY LTD, Poietis, Vivax Bio, LLC, Allevi, Cyfuse Biomedical K.K., 3D Bioprinting Solutions, Cellink Global, Regemat 3D S.L., among others.
The 3d Bioprinting market is segmented as follows:
Parameter
Details
Market Size Provided for Years
2016-2028
Base Year
2021
Historic Years
2016-2020
Forecast Years
2022-2028
Segments Covered
Region & Counties Covered
Companies Covered
Report Coverage
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
impact analysis
Frequently Asked Questions
-
What is
the global demand for 3d Bioprinting
in terms of revenue?
The global 3d Bioprinting valued at USD 1.5 Billion in 2020 and is expected to reach USD 1.8 Billion in 2028 growing at a CAGR of 13.6%
-
Which
are the prominent players
in the market?
The prominent players in the market are Envisiontec, Inc., Organovo Holdings, Inc., Inventia Life Science PTY LTD, Poietis, Vivax Bio, LLC, Allevi, Cyfuse Biomedical K.K., 3D Bioprinting Solutions, Cellink Global, Regemat 3D S.L..
-
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 13.6% between 2021 and 2028.
-
What are
the driving factors
fueling the growth of the market.
The driving factors of the 3d Bioprinting include
- Technological Advancements in the 3D Bioprinting Industry
-
Which
region accounted for the
largest share in the market?
North America was the leading regional segment of the 3d Bioprinting in 2020.
Choose License
Our Companies
